Biotherapeutics are key in the treatment and prevention of a host of illnesses and diseases. The manufacture of these life-saving medicines is a complex process that requires substantial investments of time and resources.
Microarray testing can be leveraged to assist in the research, Quality Control, and in-process testing stages of biotherapeutic development and manufacture.
Currently, with support from the National Institute of Allergy and Infectious Diseases, we are developing a new protein analysis platform (VaxArray® Influenza) that will revolutionize protein quantification for vaccine and biotherapeutic developers.
Continue to check here and our Research & Development page for updates on VaxArray Influenza and other products.